Skip Navigation

JNCI Journal of the National Cancer Institute 2001 93(22):1753; doi:10.1093/jnci/93.22.1753
© 2001 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Li, C. I.
Right arrow Articles by Daling, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, C. I.
Right arrow Articles by Daling, J. R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 93, No. 22, 1753, November 21, 2001
© 2001 Oxford University Press

CORRESPONDENCE

Re: Tamoxifen and Contralateral Breast Cancer: the Other Side

Christopher I. Li, Kathleen E. Malone, Noel S. Weiss, Janet R. Daling

Affiliation of authors: Fred Hutchinson Cancer Research Center, Division of Public Health Sciences, Seattle, WA.

Correspondence to: Christopher I. Li, M.D., M.P.H., Fred Hutchinson Cancer Research Center, Division of Public Health Sciences, 1100 Fairview Ave., N., MP 381, P.O. Box 19024, Seattle, WA 98109–1024 (e-mail: cili@fhcrc.org).

In her editorial (1) regarding our report (2) on the relationship between tamoxifen therapy for primary breast cancer and risk of contralateral breast cancer by estrogen receptor (ER) status, Dr. Swain comments that we "did not find a statistically significant reduction in contralateral breast cancer in women treated with adjuvant tamoxifen, with a hazard ratio [HR]) of 0.9 (95% confidence interval [CI] = 0.7 to 1.2). This negative finding seriously calls into question the . . . [Full Text of this Article]

NOTES

REFERENCES


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?